Name (Synonyms) | Correlation | |
---|---|---|
drug2501 | SARS-CoV-2-test Wiki | 1.00 |
drug2491 | SARS-CoV-2 convalescent plasma Wiki | 0.58 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a pandemic disease with worldwide spreading. Limited data are existed regarding SARS-CoV-2 positive carriers among asymptomatic medical employees in non-profile infectious clinic, e.g. cardiovascular clinic, routinely working in the pandemic region with two million inhabitants. The aim is to test the percentage and increase of the SARS-CoV-2 positive carriers among asymptomatic medical employees in high-volume cardiovascular center in routine clinical practice.
Description: Percentage of SARS-CoV-2 positive tests and increase of SARS-CoV-2 positive test between 1 st , 2 nd and 3 rd time frame testing
Measure: SARS-CoV-2 positive test Time: 8 weeksDescription: Percentage of transformation from asymptomatic SARS-CoV-2 positive carriers to symptomatic form
Measure: Transformation Time: 8 weeksDescription: Predictors of the asymptomatic SARS-CoV-2 positive carriers
Measure: Predictors (asymptomatic) Time: 8 weeksDescription: Predictors of symptomatic form transformation
Measure: Predictors (symptomatic) Time: 8 weeksDescription: Percentage of employees from different departments with SARS-CoV-2 positive carriers
Measure: Percentage from different departments Time: 8 weeks